Focus: Blacksmith Medicines is a San Diego-based biotech company focused on human metalloenzyme-targeted medicines, operating in ophthalmology and neurology. The company is public-stage with a specialized, precision-focused therapeutic approach.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Growing — net +5 jobs in 30d
5 jobs added vs 0 removed. Steady team buildout.
Best suited for specialists seeking deep science in a niche mechanism with public-company optionality, but limited hiring and pipeline transparency create execution risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Established NDA product with approaching loss of exclusivity, representing legacy revenue subject to generic erosion.
Help build intelligence for Blacksmith Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Blacksmith Medicines's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles